Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.77% | $183.08M | €334.77B | 38.25% | 76 Outperform | |
| AstraZeneca | 1.95% | $128.68M | £210.71B | 35.34% | 76 Outperform | |
| Roche Holding AG | 1.91% | $126.13M | CHF230.07B | 39.34% | 73 Outperform | |
| Nestlé SA | 1.80% | $118.52M | CHF201.86B | 12.62% | 71 Outperform | |
| SAP SE | 1.75% | $115.29M | €241.59B | -5.92% | 66 Neutral | |
| Novartis AG | 1.70% | $112.56M | CHF201.32B | 12.01% | 80 Outperform | |
| HSBC Holdings | 1.70% | $112.02M | £187.79B | 45.80% | 79 Outperform | |
| Shell (UK) | 1.55% | $102.29M | £164.04B | 9.52% | 77 Outperform | |
| Siemens | 1.35% | $89.43M | €174.65B | 24.00% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.25% | $82.43M | €310.18B | 5.92% | 78 Outperform |